Pharmascience’s $120-million expansion of its injectable-drug manufacturing plant in suburban Montreal is well underway, says the company.

The plant is located in Candiac, Que. Pharmascience provided an update on the project while announcing the expansion of its contract development and manufacturing organization services.

Montreal-based Pharmascience has created a new business unit dedicated to injectable products. 

Pharmascience said the expanded plant will support more patients, with annual production rising to more than 20 million units. The project will also enable Pharmascience to compete with international players and broaden its client base with a new range of products and services, said the company.

Announced in October, the project will triple Pharmascience’s current injectable-drug manufacturing capacity from its 2021 level.

The expansion will comprise 26,000 square feet of new manufacturing space and equipment. Plans also call for 7,500 sf in retrofits.

The federal government is investing $29.77 million through its strategic innovation fund. Meanwhile, the Quebec government is providing $24.75 million.